Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
KEVZARA SANOFI-AVENTIS CANADA INC Actual shortage 150MG Updated Report 2022-05-28 159316
OMNIPAQUE 240 GE HEALTHCARE CANADA INC Actual shortage 518MG Updated Report 2022-05-28 160525
QUELICIN PFIZER CANADA ULC Actual shortage 20MG Updated Report 2022-05-28 161418
REDDY-ABIRATERONE DR REDDY'S LABORATORIES LTD Actual shortage 250MG Updated Report 2022-05-28 161431
LONITEN 10MG PFIZER CANADA ULC Actual shortage 10MG Updated Report 2022-05-28 155743
CALCIJECT INJ 100MG/ML OMEGA LABORATORIES LIMITED Actual shortage 100MG Updated Report 2022-05-28 160184
ATROPINE SULFATE INJECTION LABORATOIRE AGUETTANT Actual shortage 1MG Updated Report 2022-05-28 161106
ACH-OLMESARTAN ACCORD HEALTHCARE INC Actual shortage 20MG Updated Report 2022-05-28 161325
ACH-OLMESARTAN ACCORD HEALTHCARE INC Actual shortage 40MG Updated Report 2022-05-28 161328
ACH-ROSUVASTATIN ACCORD HEALTHCARE INC Actual shortage 5MG Updated Report 2022-05-28 161331

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
GALLIUM LANTHEUS MI CANADA INC To be discontinued 74MBq New Report 2022-05-27 161428
THALLIUM LANTHEUS MI CANADA INC To be discontinued 2MCI New Report 2022-05-27 161424
SANDOZ METHYLPHENIDATE SR SANDOZ CANADA INCORPORATED Discontinued 20MG New Report 2022-05-24 161221
SANDOZ TOPIRAMATE TABLETS SANDOZ CANADA INCORPORATED Discontinued 200MG New Report 2022-05-24 161216
SANDOZ TOPIRAMATE TABLETS SANDOZ CANADA INCORPORATED Discontinued 100MG New Report 2022-05-24 161211
SANDOZ TOPIRAMATE TABLETS SANDOZ CANADA INCORPORATED Discontinued 25MG New Report 2022-05-24 161206
IMOVANE SANOFI-AVENTIS CANADA INC To be discontinued 5.0MG Updated Report 2022-05-16 160688
HEPTOVIR GLAXOSMITHKLINE INC To be discontinued 5MG New Report 2022-05-13 160503
HEPTOVIR GLAXOSMITHKLINE INC To be discontinued 100MG New Report 2022-05-13 160500
APO-BICALUTAMIDE APOTEX INC Discontinued 50MG Updated Report 2022-05-13 157376